Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-07 Sale | 2024-11-12 4:05 pm | Spero Therapeutics Inc. | SPRO | Rajavelu Esther CFO & CBO | 40,596 | $1.3058 | $53,008 | 379,270 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-01 Option Award | 2024-02-05 8:44 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Rajavelu Esther See Remarks | 119,866 | $0 | 419,866 (Direct) | View |
| 2023-11-13 Option Award | 2023-11-15 4:17 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Rajavelu Esther See Remarks | 300,000 | $0 | 300,000 (Direct) | View |
| 2023-02-09 Option Award | 2023-02-13 4:15 pm | N/A 2033-02-08 | Fulcrum Therapeutics Inc. | FULC | Rajavelu Esther Chief Financial Officer | 160,000 | $0 | 160,000 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-10 4:30 pm | N/A 2032-01-02 | Fulcrum Therapeutics Inc. | FULC | Rajavelu Esther Chief Financial Officer | 200,000 | $0 | 200,000 (Direct) | View |
Ownership | 2022-01-10 4:16 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Rajavelu Esther Chief Financial Officer | 0 | $0 | 0 (Direct) | View |